Cryosite（CTE）株式概要Cryosite社は、オーストラリアで臨床試験ロジスティクスのアウトソーシングサービスを提供している。 詳細CTE ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績5/6財務の健全性3/6配当金0/6報酬株価収益率（ 27.3 x）は、 Life Sciences業界平均（ 38.9 x）を下回っています。過去1年間で収益は18.6%増加しました リスク分析株式の流動性は非常に低い 多額の負債を抱えている 意味のある時価総額がありません ( A$61M )すべてのリスクチェックを見るCTE Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW464,325 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA464,325 investors already sharing narrativesYour Fair ValueAU$Current PriceAU$1.253.1% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-565k25m2016201920222025202620282031Revenue AU$25.3mEarnings AU$3.4mAdvancedSet Fair ValueView all narrativesCryosite Limited 競合他社BLS PharmaceuticalsSymbol: ASX:BLSMarket cap: AU$217.3mLittle Green PharmaSymbol: ASX:LGPMarket cap: AU$58.0mVita Life SciencesSymbol: ASX:VLSMarket cap: AU$156.7mVitura HealthSymbol: ASX:VITMarket cap: AU$16.6m価格と性能株価の高値、安値、推移の概要Cryosite過去の株価現在の株価AU$1.2552週高値AU$1.3052週安値AU$0.80ベータ0.161ヶ月の変化0%3ヶ月変化17.37%1年変化n/a3年間の変化90.84%5年間の変化184.09%IPOからの変化390.20%最新ニュースReported Earnings • Aug 19Full year 2026 earnings released: EPS: AU$0.046 (vs AU$0.039 in FY 2025)Full year 2026 results: EPS: AU$0.046 (up from AU$0.039 in FY 2025). Revenue: AU$16.7m (up 18% from FY 2025). Net income: AU$2.24m (up 19% from FY 2025). Profit margin: 13% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Aug 12No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to AU$1.25, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 36x in the Life Sciences industry globally. Total returns to shareholders of 69% over the past year.Board Change • May 22No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Board Change • May 20No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.お知らせ • Aug 18Cryosite Limited, Annual General Meeting, Oct 16, 2025Cryosite Limited, Annual General Meeting, Oct 16, 2025. Location: at the thomson geer offices, at level 23, rialto south tower, 525 collins street, melbourne vic 3004 Australia最新情報をもっと見るRecent updatesReported Earnings • Aug 19Full year 2026 earnings released: EPS: AU$0.046 (vs AU$0.039 in FY 2025)Full year 2026 results: EPS: AU$0.046 (up from AU$0.039 in FY 2025). Revenue: AU$16.7m (up 18% from FY 2025). Net income: AU$2.24m (up 19% from FY 2025). Profit margin: 13% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Aug 12No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to AU$1.25, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 36x in the Life Sciences industry globally. Total returns to shareholders of 69% over the past year.Board Change • May 22No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Board Change • May 20No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.お知らせ • Aug 18Cryosite Limited, Annual General Meeting, Oct 16, 2025Cryosite Limited, Annual General Meeting, Oct 16, 2025. Location: at the thomson geer offices, at level 23, rialto south tower, 525 collins street, melbourne vic 3004 Australiaお知らせ • Nov 22Cryosite Limited Announces Resignation of Michael Austin as Joint Company SecretaryCryosite Limited announced that Mr. Michael Austin has resigned as Joint Company Secretary, effective 22 November 2024. Mr. Hamish George of Bio101 Financial Advisory Pty Ltd. remains as Company Secretary and is responsible for communications with the ASX in relation to Listing Rule matters under ASX Listing Rule 12.6.お知らせ • Oct 21Cryosite Limited, Annual General Meeting, Nov 22, 2024Cryosite Limited, Annual General Meeting, Nov 22, 2024. Location: boardroom, level 2 90 william st, melbourne,vic, 3000., melbourne, Australiaお知らせ • Sep 20Cryosite Limited Announces Company Secretary ChangesCryosite Limited announced that Hamish George and Michael Austin of Bio101 Financial Advisory Pty Ltd. (Bio101) have been appointed Joint Company Secretaries of the Company. The appointment follows the resignation of Mr. Dray Andrea as Company Secretary, effective 20 September 2024. The Board would like to thank Mr. Andrea for his service in the role of Company Secretary.New Risk • Sep 07New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.7% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Significant insider selling over the past 3 months (AU$7.5m sold). Market cap is less than US$100m (AU$36.6m market cap, or US$24.4m).Declared Dividend • Aug 22Final dividend of AU$0.02 announcedShareholders will receive a dividend of AU$0.02. Ex-date: 6th September 2024 Payment date: 10th October 2024 Dividend yield will be 8.6%, which is higher than the industry average of 0.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share has grown by 14% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Aug 21Full year 2024 earnings released: EPS: AU$0.038 (vs AU$0.029 in FY 2023)Full year 2024 results: EPS: AU$0.038 (up from AU$0.029 in FY 2023). Revenue: AU$12.6m (up 5.7% from FY 2023). Net income: AU$1.84m (up 31% from FY 2023). Profit margin: 15% (up from 12% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 19% per year.お知らせ • Aug 20+ 2 more updatesCryosite Limited Announces Retirement of John Hogg as Chief Executive Officer, Effective October 31, 2024Cryosite announced the retirement of its Chief Executive Officer, Mr. John Hogg, with effect from October 31, 2024. The Board thanks Mr. Hogg for his support and service to the Board and the Company over his tenure.Buy Or Sell Opportunity • Jul 31Now 36% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.8% to AU$0.78. The fair value is estimated to be AU$1.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.5% over the last 3 years. Earnings per share has grown by 29%.Valuation Update With 7 Day Price Move • Jul 22Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to AU$1.05, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 34x in the Life Sciences industry globally. Total returns to shareholders of 184% over the past three years.Board Change • Jun 27No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.お知らせ • Jun 25Cryosite Limited Announces Retirement of Andrew Kroger from the Board of DirectorsCryosite Limited announced that Andrew Kroger has retired from the board of directors (Board) effective from June 25, 2024.Recent Insider Transactions • Apr 27Non Executive Director recently sold AU$830k worth of stockOn the 23rd of April, Andrew Kroger sold around 1m shares on-market at roughly AU$0.83 per share. This transaction amounted to 7.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Board Change • Apr 19No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Andrew Kerr was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Feb 22Cryosite Limited Announces Board ChangesCryosite Limited announced the appointment of Mr. Andrew Kerr as a Director of the Company. Mr. John Hogg will step down as Managing Director and continue in his current executive position as CEO of Cryosite. Andrew is an experienced financial services professional in both the Australian and international markets. Andrew is a qualified Certified Practising Accountant (CPA) and a graduate of the Australian Institute of Company Directors (GAICD) course. Through his roles at Bank of America Merrill Lynch and Macquarie Bank, Andrew has obtained strong sustainability and ESG credentials which will greatly complement the Board.Upcoming Dividend • Feb 14Upcoming dividend of AU$0.05 per share at 2.2% yieldEligible shareholders must have bought the stock before 21 February 2024. Payment date: 29 February 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (0.5%).Board Change • Feb 01No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jan 05No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Dec 17No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Dec 08Cryosite Limited Announces Director ChangesCryosite Limited announced the appointment of Mr. Mark Kerr, as a new Director and Chairman. Mr. John Hogg, CEO of Cryosite will also join the Board as the Managing Director. The only variation to Mr. Hogg's employment agreement is to reflect his new office with the Company. The company announced the retirement from the Board of Directors of Steven Waller, Nicola Swift and Luis Antonio. The Board thanks the three retiring directors for their outstanding contribution to the Company over a number of years. The retiring directors have contributed substantial hours beyond what was expected to ensure the success of the Company going forward.お知らせ • Oct 02Cryosite Limited, Annual General Meeting, Nov 23, 2023Cryosite Limited, Annual General Meeting, Nov 23, 2023, at 11:01 AUS Eastern Standard Time. Location: The offices of Cryosite, 13A Ferndell St, South Granville New South Wales Australiaお知らせ • Aug 25Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023Cryosite Limited announced dividend of AUD 0.01500000 per share for the twelve months ended June 30, 2023. Record date is September 8, 2023. Ex-date is September 7, 2023. Payment date is October 6, 2023.Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$0.014 (vs AU$0.016 in 1H 2022)First half 2023 results: EPS: AU$0.014 (down from AU$0.016 in 1H 2022). Revenue: AU$5.72m (down 1.7% from 1H 2022). Net income: AU$678.7k (down 13% from 1H 2022). Profit margin: 12% (down from 13% in 1H 2022).お知らせ • Jan 20Cryosite Limited Announces Change of Company SecretaryCryosite Limited announces the resignation of Kim Bradley-Ware and the appointment of Dray Andrea as Company Secretary, both effective January 18, 2023.Recent Insider Transactions • Jan 19Insider recently bought AU$481k worth of stockOn the 13th of January, Mark Kerr bought around 650k shares on-market at roughly AU$0.74 per share. This transaction amounted to 39% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$582k. Insiders have collectively bought AU$2.6m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Dec 24Insider recently bought AU$582k worth of stockOn the 19th of December, Mark Kerr bought around 885k shares on-market at roughly AU$0.66 per share. This transaction amounted to 79% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$2.1m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Oct 14Insider recently bought AU$447k worth of stockOn the 11th of October, Mark Kerr bought around 600k shares on-market at roughly AU$0.74 per share. This transaction amounted to 63% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$1.6m more in shares than they have sold in the last 12 months.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Mar 03Non Executive Director recently bought AU$321k worth of stockOn the 28th of February, Andrew Kroger bought around 716k shares on-market at roughly AU$0.45 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$931k more in shares than they have sold in the last 12 months.Reported Earnings • Feb 26First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.016 (up from AU$0.006 in 1H 2021). Revenue: AU$5.82m (up 19% from 1H 2021). Net income: AU$782.4k (up 175% from 1H 2021). Profit margin: 13% (up from 5.8% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.Board Change • Feb 26Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jan 05Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Dec 11Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Oct 05Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Aug 27Full year 2021 earnings released: EPS AU$0.014 (vs AU$0.032 in FY 2020)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: AU$10.1m (up 12% from FY 2020). Net income: AU$652.6k (down 56% from FY 2020). Profit margin: 6.5% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses.Recent Insider Transactions • Jun 11Non Executive Director recently bought AU$170k worth of stockOn the 8th of June, Andrew Kroger bought around 473k shares on-market at roughly AU$0.36 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$173k more in shares than they have sold in the last 12 months.株主還元CTEAU Life SciencesAU 市場7D0%-1.7%-1.0%1Yn/a21.5%-0.1%株主還元を見る業界別リターン: CTEがAustralian Life Sciences業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: CTE Australian市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is CTE's price volatile compared to industry and market?CTE volatilityCTE Average Weekly Movementn/aLife Sciences Industry Average Movement16.2%Market Average Movement9.7%10% most volatile stocks in AU Market16.8%10% least volatile stocks in AU Market3.9%安定した株価: CTEの株価は、 Australian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のCTEのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト199927n/awww.cryosite.comクライオサイト・リミテッドは、オーストラリアで臨床試験ロジスティクスのアウトソーシングサービスを提供している。2つのセグメントで事業展開：臨床試験・生物学的サービス物流事業」と「臍帯血・組織保管事業」である。臨床試験・生物学的サービス・ロジスティクス部門は、専門家による温度管理された保管、調達、ラベリング、ステータス管理、二次包装、スケジュール薬物流通、破壊、返品、生物学的、細胞遺伝子療法のデポサービスを提供している。臍帯血・組織保管部門は、臍帯血や組織サンプルの長期保管ソリューションを提供している。同社は研究、医療、製薬、バイオテクノロジー業界にサービスを提供している。クライオサイト社は1999年に設立され、オーストラリアのサウス・グランビルに本社を置いている。もっと見るCryosite Limited 基礎のまとめCryosite の収益と売上を時価総額と比較するとどうか。CTE 基礎統計学時価総額AU$61.01m収益（TTM）AU$2.24m売上高(TTM)AU$16.70m27.3xPER（株価収益率3.7xP/SレシオCTE は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計CTE 損益計算書（TTM）収益AU$16.70m売上原価AU$6.28m売上総利益AU$10.43mその他の費用AU$8.19m収益AU$2.24m直近の収益報告Jun 30, 2026次回決算日該当なし一株当たり利益（EPS）0.046グロス・マージン62.43%純利益率13.38%有利子負債／自己資本比率116.5%CTE の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 01:45終値2026/08/12 00:00収益2026/06/30年間収益2026/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cryosite Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Aug 19Full year 2026 earnings released: EPS: AU$0.046 (vs AU$0.039 in FY 2025)Full year 2026 results: EPS: AU$0.046 (up from AU$0.039 in FY 2025). Revenue: AU$16.7m (up 18% from FY 2025). Net income: AU$2.24m (up 19% from FY 2025). Profit margin: 13% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Aug 12No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to AU$1.25, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 36x in the Life Sciences industry globally. Total returns to shareholders of 69% over the past year.
Board Change • May 22No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Board Change • May 20No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
お知らせ • Aug 18Cryosite Limited, Annual General Meeting, Oct 16, 2025Cryosite Limited, Annual General Meeting, Oct 16, 2025. Location: at the thomson geer offices, at level 23, rialto south tower, 525 collins street, melbourne vic 3004 Australia
Reported Earnings • Aug 19Full year 2026 earnings released: EPS: AU$0.046 (vs AU$0.039 in FY 2025)Full year 2026 results: EPS: AU$0.046 (up from AU$0.039 in FY 2025). Revenue: AU$16.7m (up 18% from FY 2025). Net income: AU$2.24m (up 19% from FY 2025). Profit margin: 13% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Aug 12No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to AU$1.25, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 36x in the Life Sciences industry globally. Total returns to shareholders of 69% over the past year.
Board Change • May 22No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Board Change • May 20No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
お知らせ • Aug 18Cryosite Limited, Annual General Meeting, Oct 16, 2025Cryosite Limited, Annual General Meeting, Oct 16, 2025. Location: at the thomson geer offices, at level 23, rialto south tower, 525 collins street, melbourne vic 3004 Australia
お知らせ • Nov 22Cryosite Limited Announces Resignation of Michael Austin as Joint Company SecretaryCryosite Limited announced that Mr. Michael Austin has resigned as Joint Company Secretary, effective 22 November 2024. Mr. Hamish George of Bio101 Financial Advisory Pty Ltd. remains as Company Secretary and is responsible for communications with the ASX in relation to Listing Rule matters under ASX Listing Rule 12.6.
お知らせ • Oct 21Cryosite Limited, Annual General Meeting, Nov 22, 2024Cryosite Limited, Annual General Meeting, Nov 22, 2024. Location: boardroom, level 2 90 william st, melbourne,vic, 3000., melbourne, Australia
お知らせ • Sep 20Cryosite Limited Announces Company Secretary ChangesCryosite Limited announced that Hamish George and Michael Austin of Bio101 Financial Advisory Pty Ltd. (Bio101) have been appointed Joint Company Secretaries of the Company. The appointment follows the resignation of Mr. Dray Andrea as Company Secretary, effective 20 September 2024. The Board would like to thank Mr. Andrea for his service in the role of Company Secretary.
New Risk • Sep 07New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.7% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Significant insider selling over the past 3 months (AU$7.5m sold). Market cap is less than US$100m (AU$36.6m market cap, or US$24.4m).
Declared Dividend • Aug 22Final dividend of AU$0.02 announcedShareholders will receive a dividend of AU$0.02. Ex-date: 6th September 2024 Payment date: 10th October 2024 Dividend yield will be 8.6%, which is higher than the industry average of 0.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share has grown by 14% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Aug 21Full year 2024 earnings released: EPS: AU$0.038 (vs AU$0.029 in FY 2023)Full year 2024 results: EPS: AU$0.038 (up from AU$0.029 in FY 2023). Revenue: AU$12.6m (up 5.7% from FY 2023). Net income: AU$1.84m (up 31% from FY 2023). Profit margin: 15% (up from 12% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 19% per year.
お知らせ • Aug 20+ 2 more updatesCryosite Limited Announces Retirement of John Hogg as Chief Executive Officer, Effective October 31, 2024Cryosite announced the retirement of its Chief Executive Officer, Mr. John Hogg, with effect from October 31, 2024. The Board thanks Mr. Hogg for his support and service to the Board and the Company over his tenure.
Buy Or Sell Opportunity • Jul 31Now 36% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.8% to AU$0.78. The fair value is estimated to be AU$1.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.5% over the last 3 years. Earnings per share has grown by 29%.
Valuation Update With 7 Day Price Move • Jul 22Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to AU$1.05, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 34x in the Life Sciences industry globally. Total returns to shareholders of 184% over the past three years.
Board Change • Jun 27No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
お知らせ • Jun 25Cryosite Limited Announces Retirement of Andrew Kroger from the Board of DirectorsCryosite Limited announced that Andrew Kroger has retired from the board of directors (Board) effective from June 25, 2024.
Recent Insider Transactions • Apr 27Non Executive Director recently sold AU$830k worth of stockOn the 23rd of April, Andrew Kroger sold around 1m shares on-market at roughly AU$0.83 per share. This transaction amounted to 7.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Board Change • Apr 19No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Andrew Kerr was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Feb 22Cryosite Limited Announces Board ChangesCryosite Limited announced the appointment of Mr. Andrew Kerr as a Director of the Company. Mr. John Hogg will step down as Managing Director and continue in his current executive position as CEO of Cryosite. Andrew is an experienced financial services professional in both the Australian and international markets. Andrew is a qualified Certified Practising Accountant (CPA) and a graduate of the Australian Institute of Company Directors (GAICD) course. Through his roles at Bank of America Merrill Lynch and Macquarie Bank, Andrew has obtained strong sustainability and ESG credentials which will greatly complement the Board.
Upcoming Dividend • Feb 14Upcoming dividend of AU$0.05 per share at 2.2% yieldEligible shareholders must have bought the stock before 21 February 2024. Payment date: 29 February 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (0.5%).
Board Change • Feb 01No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jan 05No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Dec 17No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Dec 08Cryosite Limited Announces Director ChangesCryosite Limited announced the appointment of Mr. Mark Kerr, as a new Director and Chairman. Mr. John Hogg, CEO of Cryosite will also join the Board as the Managing Director. The only variation to Mr. Hogg's employment agreement is to reflect his new office with the Company. The company announced the retirement from the Board of Directors of Steven Waller, Nicola Swift and Luis Antonio. The Board thanks the three retiring directors for their outstanding contribution to the Company over a number of years. The retiring directors have contributed substantial hours beyond what was expected to ensure the success of the Company going forward.
お知らせ • Oct 02Cryosite Limited, Annual General Meeting, Nov 23, 2023Cryosite Limited, Annual General Meeting, Nov 23, 2023, at 11:01 AUS Eastern Standard Time. Location: The offices of Cryosite, 13A Ferndell St, South Granville New South Wales Australia
お知らせ • Aug 25Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023Cryosite Limited announced dividend of AUD 0.01500000 per share for the twelve months ended June 30, 2023. Record date is September 8, 2023. Ex-date is September 7, 2023. Payment date is October 6, 2023.
Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$0.014 (vs AU$0.016 in 1H 2022)First half 2023 results: EPS: AU$0.014 (down from AU$0.016 in 1H 2022). Revenue: AU$5.72m (down 1.7% from 1H 2022). Net income: AU$678.7k (down 13% from 1H 2022). Profit margin: 12% (down from 13% in 1H 2022).
お知らせ • Jan 20Cryosite Limited Announces Change of Company SecretaryCryosite Limited announces the resignation of Kim Bradley-Ware and the appointment of Dray Andrea as Company Secretary, both effective January 18, 2023.
Recent Insider Transactions • Jan 19Insider recently bought AU$481k worth of stockOn the 13th of January, Mark Kerr bought around 650k shares on-market at roughly AU$0.74 per share. This transaction amounted to 39% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$582k. Insiders have collectively bought AU$2.6m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Dec 24Insider recently bought AU$582k worth of stockOn the 19th of December, Mark Kerr bought around 885k shares on-market at roughly AU$0.66 per share. This transaction amounted to 79% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$2.1m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Oct 14Insider recently bought AU$447k worth of stockOn the 11th of October, Mark Kerr bought around 600k shares on-market at roughly AU$0.74 per share. This transaction amounted to 63% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$1.6m more in shares than they have sold in the last 12 months.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Mar 03Non Executive Director recently bought AU$321k worth of stockOn the 28th of February, Andrew Kroger bought around 716k shares on-market at roughly AU$0.45 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$931k more in shares than they have sold in the last 12 months.
Reported Earnings • Feb 26First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.016 (up from AU$0.006 in 1H 2021). Revenue: AU$5.82m (up 19% from 1H 2021). Net income: AU$782.4k (up 175% from 1H 2021). Profit margin: 13% (up from 5.8% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.
Board Change • Feb 26Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jan 05Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Dec 11Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Oct 05Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Aug 27Full year 2021 earnings released: EPS AU$0.014 (vs AU$0.032 in FY 2020)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: AU$10.1m (up 12% from FY 2020). Net income: AU$652.6k (down 56% from FY 2020). Profit margin: 6.5% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses.
Recent Insider Transactions • Jun 11Non Executive Director recently bought AU$170k worth of stockOn the 8th of June, Andrew Kroger bought around 473k shares on-market at roughly AU$0.36 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$173k more in shares than they have sold in the last 12 months.
